Mechanism of signal transduction that regulates osteoclast differentiation and its abnormalities in bone distructive diseases
骨破坏性疾病中破骨细胞分化及其异常的信号转导机制
基本信息
- 批准号:11470227
- 负责人:
- 金额:$ 7.87万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Cloning of RANKL-induced early genes in osteoclast progenitorsHuman leukemia cell line, HL60, expressed RANK upon differentiation induced by TPA and 1, 25-vitamin D. RANKL treatment of thus induced HL60 cells led to further up-regulation of RANK.Meanwhile, we have identified several RANKL target genes with suppression PCR methods by stimulating osteoclast progenitors including primary mouse spleen cells and a mouse preosteoclast cell line, C7, with RANKL for one to four hours. Among such genes are cathepsins and uncharacterized transcription factors. Elucidation of RANKL signaling pathways that induce these target genes would lead to identification of master genes that regulates osteoclast differentiation.2. Mechanism of osteoclast induction by multiple myeloma (MM) cellsWe demonstrated macrophage inflammatory protein (MIP)-1 alpha and beta are abundantly produced by MM cells. These chemokines not only induced RANKL expression by stromal cells via their common receptor CCR5, but also acts in an autocrine/paracrine fashion to activate VLA-4 on MM cells, thereby enhancing cellular interactions with stromal cells which express VCAM-1 on their surface. We also found that MIP-1 enhances binding of MM cells to osteoclasts. Proliferation and survival of MM cells was enhanced by the presence of osteclasts in a manner dependent on direct cell-cell interactions. These effects appeared to involve matrix proteins such as osteopontin abundantly produced by osteoclasts as well as interleukin-6, a known growth factor for MM cells.Taken together, these results suggested that complex cellular interactions in the bone marrow milieu, in which MIP-1 may play a central role, leads to not only efficient activation of osteoclasts but also enhancement of MM proliferation and survival, thereby causing a vicious cycle that leads to profound bone destruction.
1. 克隆RANKL诱导的破骨细胞祖细胞人白血病细胞株HL60的早期基因,在TPA和1,25 -维生素d诱导分化后表达RANK。RANKL处理由此诱导的HL60细胞可进一步上调RANK。同时,我们通过抑制PCR方法,用RANKL刺激破骨细胞祖细胞(包括原代小鼠脾细胞和小鼠破骨细胞前细胞系C7) 1至4小时,鉴定了几个RANKL靶基因。这些基因包括组织蛋白酶和未表征的转录因子。阐明诱导这些靶基因的RANKL信号通路将有助于鉴定调控破骨细胞分化的主控基因。多发性骨髓瘤(MM)细胞诱导破骨细胞的机制我们证实了巨噬细胞炎症蛋白(MIP)-1 α和β是由MM细胞大量产生的。这些趋化因子不仅通过其共同受体CCR5诱导基质细胞表达RANKL,而且还以自分泌/旁分泌的方式激活MM细胞上的vla4,从而增强细胞与在其表面表达VCAM-1的基质细胞的相互作用。我们还发现MIP-1增强MM细胞与破骨细胞的结合。成骨细胞的存在以依赖于直接细胞间相互作用的方式增强了MM细胞的增殖和存活。这些影响似乎涉及基质蛋白,如破骨细胞大量产生的骨桥蛋白,以及白细胞介素-6,一种已知的MM细胞生长因子。综上所述,这些结果表明骨髓环境中复杂的细胞相互作用,其中MIP-1可能发挥核心作用,不仅导致破骨细胞的有效活化,而且还增强MM的增殖和存活,从而导致恶性循环,导致严重的骨破坏。
项目成果
期刊论文数量(106)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeuchi Y, et al.: "Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice"Journal of Biological Chemistry. 277. 49011-49018 (2002)
Takeuchi Y 等人:“Interleukin-11 作为骨形成的刺激因子,可防止小鼠随着年龄增长而骨质流失”《生物化学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kitagawa H, et al.: "Ligand selective potentiation of rat mineralocorticoid receptor activation function-1 (AF-1) by a CBP-containing HAT complex"Mol Cell Biol. 22. 3698-706 (2002)
Kitakawa H 等人:“含有 CBP 的 HAT 复合物对大鼠盐皮质激素受体激活功能 1 (AF-1) 的配体选择性增强”Mol Cell Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Saika M, et al.: "17-beta estradiol stimulates expression of osteoprotegerin (OPG) by a mouse stromal cell line, ST-2, via estrogen receptor alpha"Endocrinology. 142・6. 2205-2212 (2001)
Saika M 等人:“17-β 雌二醇通过雌激素受体 α 刺激小鼠基质细胞系 ST-2 表达骨保护素 (OPG)”内分泌学 142·6 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe M, et al.: "Interleukin-1b (IL-1b) enhances and interferon g (IFNg) suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts"Clin Exp Immunol. 126. 64-68 (2001)
Abe M 等人:“白细胞介素 1b (IL-1b) 通过相互调节骨髓基质成纤维细胞的激活素 A 和卵泡抑素分泌来增强激活素 A 的作用,而干扰素 g (IFNg) 则抑制激活素 A 的作用”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Saika M, et al.: "17beta-Estradiol Stimulates Expression of Osteoprotegerin (OPG) by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-alpha."Endocrinology. (発表予定). (2001)
Saika M 等人:“17β-雌二醇通过雌激素受体-α 刺激小鼠基质细胞系 ST-2 表达骨保护素 (OPG)”。内分泌学(即将出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUMOTO Toshio其他文献
MATSUMOTO Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUMOTO Toshio', 18)}}的其他基金
Role and mechanism of action of IL-11 on the regulation of bone and adipose tissue interaction
IL-11在骨与脂肪组织相互作用调节中的作用及作用机制
- 批准号:
16H05327 - 财政年份:2016
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders
阐明骨骼稳态调节的分子机制,开发骨骼疾病的新治疗方法
- 批准号:
25293215 - 财政年份:2013
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems
骨骼、脂肪和血管调节系统之间的关系以及这些系统紊乱引起的发病机制的阐明
- 批准号:
20249050 - 财政年份:2008
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Observational study of the first stars of the Universe
对宇宙第一颗恒星的观测研究
- 批准号:
18204018 - 财政年份:2006
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular mechanic sum of the regulation and dies regulation of bone homeostasis and Development of therapeutic approaches
骨稳态调节和死亡调节的分子力学总和及治疗方法的发展
- 批准号:
17209035 - 财政年份:2005
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Differentiation-inducing signals in osteoblasts and its application for development of bone anabolic therapy
成骨细胞分化诱导信号及其在骨合成代谢治疗中的应用
- 批准号:
14370329 - 财政年份:2002
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of immunotherapy targeting neoplastic lymphocyte-specific antigen (2D7) against hematological malignancies
针对血液恶性肿瘤的肿瘤淋巴细胞特异性抗原(2D7)免疫疗法的开发
- 批准号:
13557082 - 财政年份:2001
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel agents using the method of modulating the transcriptional activity of apo (a) gene
利用调节apo(a)基因转录活性的方法开发新药物
- 批准号:
10557105 - 财政年份:1998
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Infrared Observation of Galactid Halo
银河晕的红外观测
- 批准号:
06402002 - 财政年份:1994
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of a new therapeutic approach for senile osteoporosis using bone matrix deoorin
利用骨基质脱氧蛋白开发老年骨质疏松症新治疗方法
- 批准号:
06557055 - 财政年份:1994
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
相似国自然基金
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
- 批准号:82370885
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Pre-osteoclast调控的血管-骨形成偶联在骨性关节炎发病进展中的机制研究
- 批准号:81601942
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
一个潜在的、防治骨质破坏的药物靶点的新发现
- 批准号:30670997
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis
骨细胞诱导机制和病原体引起的骨溶解的调节
- 批准号:
10648513 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
- 批准号:
23K16044 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Osteoclast fusion and regulation by DC-STAMP and OC-STAMP
DC-STAMP 和 OC-STAMP 的破骨细胞融合和调节
- 批准号:
23K16132 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Osteoclast programming and reprogramming during osteoclastogenesis
破骨细胞生成过程中的破骨细胞编程和重编程
- 批准号:
10776112 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Elucidation of the pathogenesis of glucocorticoid-induced osteoporosis targeting newly identified circulating osteoclast precursor cells
针对新发现的循环破骨细胞前体细胞阐明糖皮质激素诱导的骨质疏松症的发病机制
- 批准号:
23K08707 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of osteoclast endocrine and paracrine communications by systems genetics approaches
通过系统遗传学方法鉴定破骨细胞内分泌和旁分泌通讯
- 批准号:
10716388 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Regulation of Osteoclastogenesis and Inflammatory Osteolysis
破骨细胞生成和炎性骨质溶解的调节
- 批准号:
10681786 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
CKD-MBDにおけるOsteoclast-associated receptor (OSCAR)の役割の検討
检查破骨细胞相关受体 (OSCAR) 在 CKD-MBD 中的作用
- 批准号:
23K15233 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Gene Regulatory Nework Analysis within lving single cell including osteoclast
包括破骨细胞在内的活单细胞内的基因调控网络分析
- 批准号:
23K15736 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists